Crossref
Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?
Clinical Infection and Immunity · 2020
DOI: 10.14740/cii106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infection and Immunity, 2020. Verfasst von Shweta Sinha und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sinha, S., Sehgal, A., & Sehgal, R. (2020). Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?. Clinical Infection and Immunity. https://doi.org/10.14740/cii106
Vancouver
Sinha S, Sehgal A, Sehgal R. Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?. Clinical Infection and Immunity. 2020. doi:10.14740/cii106
BibTeX
@article{Sinha2020,
author = {Sinha, Shweta and Sehgal, Alka and Sehgal, Rakesh},
title = {Ivermectin: Is It to Be a Potent Therapeutic Option for COVID-19?},
journal = {Clinical Infection and Immunity},
year = {2020},
doi = {10.14740/cii106}
}
EUVIMED